Catalpol promotes mitochondrial biogenesis in chondrocytes

References

• Blanco, F.J., Rego, I., and Ruiz-Romero, C., 2011. The role of mitochondria in osteoarthritis. Nature reviews rheumatology, 7 (3), 161–169.
   PubMed Web of Science ®Google Scholar
• Bomzon, Z., et al., 2006. Mitochondrial dynamics in chondrocytes and their connection to the mechanical properties of the cytoplasm. Journal of biomechanical engineering, 128 (5), 674–679.
   PubMed Web of Science ®Google Scholar
• Brennan-Olsen, S.L., et al., 2017. Prevalence of arthritis according to age, sex and socioeconomic status in six low and middle income countries: analysis of data from the World Health Organization study on global AGEing and adult health (SAGE) Wave 1. BMC musculoskeletal disorders, 18 (1), 271.
   PubMed Web of Science ®Google Scholar
• Cai, Q.Y., et al., 2011. Protective effects of catalpol on oligodendrocyte death and myelin breakdown in a rat model of chronic cerebral hypoperfusion. Neuroscience letters, 497 (1), 22–26.
   PubMed Web of Science ®Google Scholar
• De Silva, V., et al., 2011. Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: a systematic review. Rheumatology, 50 (5), 911–920.
   PubMed Web of Science ®Google Scholar
• Fearon, U., et al., 2016. Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nature reviews rheumatology, 12 (7), 385–397.
   PubMed Web of Science ®Google Scholar
• Hu, H., et al., 2019. Catalpol inhibits homocysteine-induced oxidation and inflammation via inhibiting Nox4/NF-κB and GRP78/PERK pathways in human aorta endothelial cells. Inflammation, 42 (1), 64–80.
   PubMed Web of Science ®Google Scholar
• Hu, L.A., et al., 2016. Catalpol inhibits apoptosis in hydrogen peroxide-induced cardiac myocytes through a mitochondrial-dependent caspase pathway. Bioscience reports, 36 (3).
   Google Scholar
• Jornayvaz, F.R. and Shulman, G.I., 2010. Regulation of mitochondrial biogenesis. Essays in biochemistry, 47, 69–84.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2014. Hypoglycemic effect of catalpol on high-fat diet/streptozotocin-induced diabetic mice by increasing skeletal muscle mitochondrial biogenesis. Acta biochimica et biophysica sinica, 46 (9), 738–748.
   PubMed Web of Science ®Google Scholar
• Liu, J.Y., et al., 2016. Catalpol ameliorates diabetic atherosclerosis in diabetic rabbits. American journal of translational research, 8 (10), 4278–4288.
   PubMed Web of Science ®Google Scholar
• Liu, Y.F., et al., 2007. [Advances in research on pharmacodynamics and chemical conversion of catalpol]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China journal of Chinese materia medica, 32 (12), 1128–1130.
   PubMedGoogle Scholar
• Macfarlane, G.J., et al., 2012. A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: osteoarthritis. Rheumatology, 51 (12), 2224–2233.
   PubMed Web of Science ®Google Scholar
• Mignotte, F., et al., 1991. Mitochondrial biogenesis in rabbit articular chondrocytes transferred to culture. Biology of the cell, 71 (1–2), 67–72.
   PubMed Web of Science ®Google Scholar
• Puigserver, P., et al., 1999. Activation of PPARgamma coactivator-1 through transcription factor docking. Science, 286 (5443), 1368–1371.
   PubMed Web of Science ®Google Scholar
• Puigserver, P. and Spiegelman, B.M., 2003. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrine reviews, 24 (1), 78–90.
   PubMed Web of Science ®Google Scholar
• Scarpulla, R.C., 2002. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene, 286 (1), 81–89.
   PubMed Web of Science ®Google Scholar
• Scarpulla, R.C., 2011. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et biophysica acta, 1813 (7), 1269–1278.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2019. Montelukast promotes mitochondrial biogenesis via CREB/PGC-1α in human bronchial epithelial cells. Artificial cells, nanomedicine, and biotechnology, 47 (1), 4234–4239.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2015. Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α. Arthritis & rheumatology, 67 (8), 2141–2153.
   PubMed Web of Science ®Google Scholar
• Wang, Z., et al., 2018. Catalpol inhibits amyloid-β generation through promoting α-cleavage of APP in Swedish mutant APP overexpressed N2a cells. Frontiers in aging neuroscience, 10, 66.
   PubMed Web of Science ®Google Scholar
• Wu, L., et al., 2014. Mitochondrial pathology in osteoarthritic chondrocytes. Current drug targets, 15 (7), 710–719.
   PubMed Web of Science ®Google Scholar
• Xu, Z., et al., 2015. Mitochondrial fusion/fission process involved in the improvement of catalpol on high glucose-induced hepatic mitochondrial dysfunction. Acta biochimica et biophysica sinica, 47 (9), 730–740.
   PubMed Web of Science ®Google Scholar
• Yao, K., et al., 2016. Carvedilol promotes mitochondrial biogenesis by regulating the PGC-1/TFAM pathway in human umbilical vein endothelial cells (HUVECs). Biochemical and biophysical research communications, 470 (4), 961–966.
   PubMed Web of Science ®Google Scholar
• Zhang, A., et al., 2009. Effects of catalpol on mitochondrial function and working memory in mice after lipopolysaccharide-induced acute systemic inflammation. Experimental and toxicologic pathology, 61 (5), 461–469.
   PubMedGoogle Scholar
• Zhang, N.D., et al., 2016. Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery. Journal of ethnopharmacology, 189, 61–80.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2008. Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa. Phytomedicine, 15 (6–7), 484–490.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2010. Systemic administration of catalpol prevents d-galactose induced mitochondrial dysfunction in mice. Neuroscience letters, 473 (3), 224–228.
   PubMed Web of Science ®Google Scholar
• Zheng, X.W., et al., 2017. Neuroprotection of catalpol for experimental acute focal ischemic stroke: preclinical evidence and possible mechanisms of antioxidation, anti-inflammation, and antiapoptosis. Oxidative medicine and cellular longevity, 2017, 1–24.
   Web of Science ®Google Scholar